TrialScientific reports2022
A randomized trial assessing the efficacy of Silymarin on endometrioma-related manifestations.
Negin Mirzaei et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this paperpooled itcites it